tES Modalities for the Treatment of ADHD

Launched by THE NATIONAL BRAIN MAPPING LABORATORY (NBML) · May 8, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to help treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and teenagers using a technique called transcranial electrical stimulation (tES). There are two specific methods being studied: transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). The goal is to see if these treatments can improve symptoms of ADHD, which affects focus and behavior.

To participate in the trial, children and teens aged 7 to 18 who have been diagnosed with ADHD by a qualified psychiatrist may be eligible. Parents will need to provide written consent for their child to join. However, individuals with other neurodevelopmental or neurological disorders, a history of brain surgery, certain metal implants, or uncontrolled epilepsy in the past year cannot take part in the study. If your child is selected, they will receive the tES treatment and be monitored to see how it helps with their ADHD symptoms. This trial is currently looking for participants, so it’s a good opportunity for families seeking new treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist
• • being 7-18 years old
• • providing written informed consent signed by parents
• Exclusion Criteria:
• • comorbidity with other neurodevelopmental disorders
• • Comorbidity with other neurological disorders
• • previous history of neurosurgery
• • Presence of any ferromagnetic metal in the head
• • implanted medical devices in the head or neck region
• • history of non-controlled epilepsy with seizures in the last year